Regeneron Pharmaceuticals Inc. buy Wells Fargo & Company
Start price
10.01.25
/
50%
€693.60
Target price
10.01.26
€875.97
Performance (%)
-1.53%
End price
11.01.26
€683.00
Summary
This prediction ended on 11.01.26 with a price of €683.00. With a performance of -1.53%, the BUY prediction by Wells_Fargo___Compan finished with a loss. Wells_Fargo___Compan has a follow-up prediction for Regeneron Pharmaceuticals Inc. where he still thinks Regeneron Pharmaceuticals Inc. is a Buy. Dividends of €3.48 are taken into consideration when calculating the performance. Wells_Fargo___Compan has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | 3.820% | 3.820% | 13.979% |
| iShares Core DAX® | 0,75 % | -8,50 % | 2,57 % |
| iShares Nasdaq 100 | -1,41 % | -2,77 % | 15,68 % |
| iShares Nikkei 225® | 0,42 % | -9,29 % | 29,65 % |
| iShares S&P 500 | -0,59 % | -2,87 % | 9,96 % |
Comments by Wells_Fargo___Compan for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) had its price target lowered by analysts at Wells Fargo & Company from $1,050.00 to $900.00. They now have an "overweight" rating on the stock.
Ratings data for REGN provided by MarketBeat
In the thread Trading Regeneron Pharmaceuticals Inc.
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten
Current prediction by Wells_Fargo___Compan for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€519.00
30.04.25
30.04.25
€615.65
30.04.26
30.04.26
29.28%
17:56
17:56
Stopped prediction by Wells_Fargo___Compan for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€995.60
23.09.24
23.09.24
€1,078.7
23.09.25
23.09.25
-51.79%
24.09.25
24.09.25
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€992.60
02.08.24
02.08.24
€1,099.3
02.08.25
02.08.25
-51.42%
03.08.25
03.08.25